To evaluate the clinical and cognitive performance of inhalant users and the clinic effects of consumption time.Ī cross-sectional study in which 28 adult users of inhalants were included, divided in two groups according to their consumption time: less than or greater than seven years. Due to the inherent difficulties of working with this population, so far there has been no quantifiable clinical evidence of the cognitive characteristics of inhalants users in early withdrawal and the clinic effect of consumption time. Inhalant use disorder has increased in spite of its adverse medical consequences. Informative and in-site harm reduction measures are warranted to prevent harms from inhalant use. Gay men had significantly higher odds of inhalant use compared to lesbians and bisexuals. LGB population is at elevated risk of inhalant use and of concurrent use with other drugs. Use of marijuana (aOR = 2.76, 95%CI = ), other illegal drugs (aOR = 2.70, 95%CI = ), and non-medical use of psychotherapeutics (aOR = 2.67, 95%CI = 1.77,4.05) were associated with past-year use of inhalants among L/G. Among L/G, men had higher odds of lifetime (aOR = 4.11, 95%CI = ) and past-year (aOR = 15.67, 95%CI = ) inhalant use versus women. Lesbian/gay population (L/G) and bisexuals (B) reported higher odds of lifetime (L/G: aOR = 3.71, 95%CI =, B: aOR = 1.82, 95%CI =, B: aOR = 2.81, 95%CI = ) inhalant use compared to heterosexuals. Total prevalences of lifetime and past-year use of inhalants were 9.4% and 0.5%, respectively. We investigated the associations between inhalant use with sexual identity categories heterosexual, lesbian/gay, and bisexual using logistic regression models with complex survey design. Participants ages 18 or older were asked if they had used any inhalants in their lifetime and past-year. The aims of this study are to: i) investigate associations between inhalant use and sexual identity groups ii) examine associations with use of other drugs among lesbian/gays who use inhalants.ĭata came from the 2015–2018 NSDUH (n = 168,560). US epidemiologic inhalants data are scarce. Inhalants are commonly used by the LGB population, who are vulnerable to their harms. Inhalants are substances with underestimated abuse potential associated with cardiac problems, dizziness, seizures, and decreased level of consciousness.
0 Comments
Leave a Reply. |